PMID- 19304328 OWN - NLM STAT- MEDLINE DCOM- 20090706 LR - 20171116 IS - 1872-8421 (Electronic) IS - 0165-5728 (Linking) VI - 210 IP - 1-2 DP - 2009 May 29 TI - KIR2DL4 (CD158d) polymorphisms and susceptibility to multiple sclerosis. PG - 113-5 LID - 10.1016/j.jneuroim.2009.03.001 [doi] AB - Several lines of evidence implicate CD56(bright) NK cells in the pathogenesis of multiple sclerosis (MS). This proposed immunoregulatory pathway involves already established susceptibility genes such as interleukin-2 receptor alpha (IL2RA) and interleukin-7 receptor (IL7R). We therefore investigated the CD56(bright) NK cell effector molecule KIR2DL4 for its involvement in genetic susceptibility to MS in a study population of 763 cases and 967 controls. Whereas 26% of the study population has a genotype corresponding to a lack of any functional membrane-bound form of the molecule, no association of the KIR2DL4 transmembrane alleles with susceptibility to MS was observed. FAU - Goris, An AU - Goris A AD - Katholieke Universiteit Leuven, Belgium. An.Goris@med.kuleuven.be FAU - Dobosi, Rita AU - Dobosi R FAU - Boonen, Steven AU - Boonen S FAU - Nagels, Guy AU - Nagels G FAU - Dubois, Benedicte AU - Dubois B LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Netherlands TA - J Neuroimmunol JT - Journal of neuroimmunology JID - 8109498 RN - 0 (CD56 Antigen) RN - 0 (Genetic Markers) RN - 0 (KIR2DL4 protein, human) RN - 0 (Receptors, KIR2DL4) SB - IM MH - Adult MH - CD56 Antigen/metabolism MH - Cell Membrane/genetics/immunology/metabolism MH - DNA Mutational Analysis MH - Female MH - Gene Frequency/genetics MH - Genetic Markers/genetics MH - Genetic Predisposition to Disease/*genetics MH - Genetic Testing MH - Genotype MH - Humans MH - Killer Cells, Natural/immunology MH - Male MH - Middle Aged MH - Multiple Sclerosis/*genetics/immunology/physiopathology MH - Polymorphism, Genetic/*genetics MH - Predictive Value of Tests MH - Receptors, KIR2DL4/*genetics MH - Young Adult EDAT- 2009/03/24 09:00 MHDA- 2009/07/07 09:00 CRDT- 2009/03/24 09:00 PHST- 2008/11/28 00:00 [received] PHST- 2009/03/02 00:00 [revised] PHST- 2009/03/02 00:00 [accepted] PHST- 2009/03/24 09:00 [entrez] PHST- 2009/03/24 09:00 [pubmed] PHST- 2009/07/07 09:00 [medline] AID - S0165-5728(09)00092-7 [pii] AID - 10.1016/j.jneuroim.2009.03.001 [doi] PST - ppublish SO - J Neuroimmunol. 2009 May 29;210(1-2):113-5. doi: 10.1016/j.jneuroim.2009.03.001.